ARCHIVES

Interview with FDA’s Richard Pazdur

This article is from The Cancer Letter archive.

Vol. 35 No. 40 | October 30, 2009

Download PDF Visit The Full Archive

Related Articles

Waksal To Pay Back $800,000 In Profits From Stock Sales

March 14, 2003

In Brief: NIH Reviewers, Advisors To Get Increase In Honoraria; Price Leaving NCI for Maryland

March 14, 1980

Breaking With Tradition, NIH Director Heads Obama’s Search for NCI Director.

February 12, 2010

NCAB Opposes Line Item for Centers

May 23, 1980

NCA Urges Pay Line Adjustment To Cut Back On Grant Duplications

October 10, 1980

Intramural Clinical Research Could Lose “Critical Mass” – Chabner

November 11, 1994